Effect of preoperative oral nutritional supplements on clinical outcomes in patients undergoing surgery for gastrointestinal cancer: A systematic review and meta-analysis
QingHua Zou,ZhaoChuan Yin,LiLi Ding,Jiang Ruan,GuoYun Zhao,XiaoQiong Wang,YiJun Li,QingWen Xu,XueJing Gong,WenShuo Liu,KaiWen Shi,WeiMing Li
DOI: https://doi.org/10.1097/md.0000000000039844
IF: 1.6
2024-09-29
Medicine
Abstract:Gastrointestinal cancer is one of the most common cancers, and malnutrition is exceedingly common in patients with gastrointestinal cancer. [ 1 ] Malnutrition is an independent risk factor for poor prognosis in surgical patients [ 2 ] and can lead to increased postoperative complications, prolonged hospital stay, increased medical costs, delayed recovery of gastrointestinal function, and seriously affect patient quality of life. [ 3–6 ] At present, surgical resection remains the main treatment for gastrointestinal cancer. However, relevant studies [ 4 , 7 ] have shown that preoperative malnutrition has a negative effect on the clinical prognosis of patients undergoing gastrointestinal cancer surgery, seriously affecting postoperative rehabilitation. Therefore, it is particularly important to improve the nutritional status of patients through reasonable nutritional support before surgery. Domestic and foreign nutritional guidelines [ 8 , 9 ] suggest that patients with nutritional risks and (or) malnutrition should receive preoperative nutritional support therapy for 7 to 14 days. Oral nutritional supplements (ONS) is preferred for patients that have a functional gastrointestinal tract and can eat orally. ONS refers to nutritional preparations that can provide patients with a variety of macro and micronutrients for the purpose of increasing nutrient intake. [ 9 ] ONS is simple, convenient, and compliant with human physiology. [ 10 ] It is an effective nutritional treatment for enhancing protein, fat, carbohydrate, mineral, and vitamin intake, and providing a balanced nutrient profile to surgical patients. [ 10 ] Intake of ONS can improve patient nutritional status and reduce the occurrence of postoperative adverse outcomes. [ 7 ] Several clinical studies and systematic reviews [ 11 , 12 ] 12 to 15 have shown that ONS accelerates wound healing, reduces the incidence of postoperative complications, shortens hospital stay, and improves quality of life. However, Burden et al [ 13 ] reported that standard oral nutritional supplements before surgery had no effect on postoperative complications and length of hospital stay (LOS). To date, studies testing whether preoperative ONS can effectively improve the clinical outcome of patients undergoing gastrointestinal cancer surgery have drawn different conclusions, and some have had conflicting results. Therefore, the clinical benefit of preoperative ONS in patients with gastrointestinal cancer remains controversial.
medicine, general & internal